UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oxidative stress in renal dysfunction: mechanisms, clinical sequelae and therapeutic options

Journal of human hypertension, 2010-01, Vol.24 (1), p.1-8

2010

Volltextzugriff (PDF)

Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels

Diabetic medicine, 2008-03, Vol.25 (3), p.320-325

2008

Volltextzugriff (PDF)

The effect of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial

Diabetologia, 2010-10, Vol.53 (10), p.2112-2119

2010

Volltextzugriff (PDF)

More than skin deep: atherosclerosis as a systemic manifestation of psoriasis

British journal of dermatology (1951), 2009-07, Vol.161 (1), p.1-7

2009

Volltextzugriff (PDF)

Renin-Angiotensin-Aldosterone System Inhibitors in Heart Failure

Clinical pharmacology and therapeutics, 2013-10, Vol.94 (4), p.459-467

2013

Volltextzugriff (PDF)

Association between allopurinol and mortality in heart failure patients: a long-term follow-up study

International journal of clinical practice (Esher), 2009-09, Vol.63 (9), p.1327-1333

2009

Volltextzugriff (PDF)

Effect of vitamin K on vascular health and physical function in older people with vascular disease–a randomised controlled trial

The Journal of nutrition, health & aging, 2016-03, Vol.20 (3), p.325-333

2016

Volltextzugriff (PDF)

Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study

British heart journal, 2002-09, Vol.88 (3), p.229-233

2002

Volltextzugriff (PDF)

Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment

British heart journal, 2004-07, Vol.90 (7), p.765-770

2004

Volltextzugriff (PDF)

Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure

Circulation (New York, N.Y.), 2000-02, Vol.101 (6), p.594-597

2000

Volltextzugriff (PDF)

Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles

Diabetologia, 2008-05, Vol.51 (5), p.762-768

2008

Volltextzugriff (PDF)

The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus

Diabetologia, 2005-10, Vol.48 (10), p.1971-1979

2005

Volltextzugriff (PDF)

Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study

British heart journal, 2002-03, Vol.87 (3), p.229-234

2002

Volltextzugriff (PDF)

Spironolactone impairs endothelial function and heart rate variability in patients with Type 2 diabetes

Diabetologia, 2004-10, Vol.47 (10), p.1687-1694

2004

Volltextzugriff (PDF)

Myocardial fibrosis and QTc are reduced following treatment with spironolactone or amiloride in stroke survivors: A randomised placebo-controlled cross-over trial

International journal of cardiology, 2013-10, Vol.168 (6), p.5229-5233

2013

Volltextzugriff (PDF)

Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure

Heart (British Cardiac Society), 2005-06, Vol.91 (6), p.749-753

2005

Volltextzugriff (PDF)

Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension

Hypertension (Dallas, Tex. 1979), 2000-03, Vol.35 (3), p.746-751

2000

Volltextzugriff (PDF)

Left ventricular hypertrophy: reduction of blood pressure already in the normal range further regresses left ventricular mass

Heart (British Cardiac Society), 2010-01, Vol.96 (2), p.148-152

2010

Volltextzugriff (PDF)

In Vitro Generation and Stability of the Lactokinin β-Lactoglobulin Fragment (142–148)

Journal of dairy science, 2004-11, Vol.87 (11), p.3845-3857

2004

Volltextzugriff (PDF)

Effects of aldosterone and related steroids on LPS‐induced increased expression of inducible NOS in rat aortic smooth muscle cells

British journal of pharmacology, 2011-12, Vol.164 (8), p.2003-2014

2011

Volltextzugriff (PDF)

A comparison between B-type natriuretic peptide, Global Registry of Acute Coronary Events (GRACE) score and their combination in ACS risk stratification

Heart (British Cardiac Society), 2009-11, Vol.95 (22), p.1836-1842

2009

Volltextzugriff (PDF)

The prognostic significance of early and late anaemia in acute coronary syndrome

QJM : An International Journal of Medicine, 2012-05, Vol.105 (5), p.445-454

2012

Volltextzugriff (PDF)

How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?

Heart (British Cardiac Society), 1999-07, Vol.82 (1), p.57-61

1999

Volltextzugriff (PDF)

QT dispersion and sudden unexpected death in chronic heart failure

The Lancet (British edition), 1994-02, Vol.343 (8893), p.327-329

1994

Volltextzugriff (PDF)

Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care

The Lancet (British edition), 1997-11, Vol.350 (9088), p.1349-1353

1997

Volltextzugriff (PDF)

1 – 25 von 1.217

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.080)
Mit Volltextzugriff
(951)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(699)
Life Sciences & Biomedicine
(651)
Humans
(639)
Male
(398)
Biological And Medical Sciences
(355)
Medical Sciences
(306)
Female
(305)
Aged
(240)
Cardiovascular System & Cardiology
(234)
Adult
(198)
Middle Aged
(198)
Cardiac & Cardiovascular Systems
(172)
Pharmacology. Drug Treatments
(143)
Cardiology. Vascular System
(114)
Heart
(100)
Animals
(98)
Pharmacology & Pharmacy
(97)
Heart Failure
(93)
General & Internal Medicine
(90)
Double-Blind Method
(86)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Oxidative stress in renal dysfunction: mechanisms, clinical sequelae and therapeutic options

Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels

The effect of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial

More than skin deep: atherosclerosis as a systemic manifestation of psoriasis

Renin-Angiotensin-Aldosterone System Inhibitors in Heart Failure

Association between allopurinol and mortality in heart failure patients: a long-term follow-up study

Effect of vitamin K on vascular health and physical function in older people with vascular disease–a randomised controlled trial

Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study

Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment

Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure

Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles

The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus

Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study

Spironolactone impairs endothelial function and heart rate variability in patients with Type 2 diabetes

Myocardial fibrosis and QTc are reduced following treatment with spironolactone or amiloride in stroke survivors: A randomised placebo-controlled cross-over trial

Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure

Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension

Left ventricular hypertrophy: reduction of blood pressure already in the normal range further regresses left ventricular mass

In Vitro Generation and Stability of the Lactokinin β-Lactoglobulin Fragment (142–148)

Effects of aldosterone and related steroids on LPS‐induced increased expression of inducible NOS in rat aortic smooth muscle cells

A comparison between B-type natriuretic peptide, Global Registry of Acute Coronary Events (GRACE) score and their combination in ACS risk stratification

The prognostic significance of early and late anaemia in acute coronary syndrome

How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?

QT dispersion and sudden unexpected death in chronic heart failure

Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care

Suchergebnisse filtern